Literature DB >> 12502630

Diabetic retinopathy.

Donald S Fong, Lloyd Aiello, Thomas W Gardner, George L King, George Blankenship, Jerry D Cavallerano, Fredrick L Ferris, Ronald Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12502630     DOI： 10.2337/diacare.26.2007.s99

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  64 in total

1.  Retinal function in relation to improved glycaemic control in type 1 diabetes.

Authors:  S K Holfort; K Nørgaard; G R Jackson; E Hommel; S Madsbad; I C Munch; K Klemp; B Sander; M Larsen
Journal:  Diabetologia       Date:  2011-04-26       Impact factor: 10.122

Review 2.  The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Benjamin A Allaire; Michael S Song; Ronald Klein; Jinan B Saaddine
Journal:  Health Serv Res       Date:  2011-04-14       Impact factor: 3.402

3.  Diabetes Education, Specialty Care, and Self-Care Advice among Obese African American Women with Type 2 Diabetes.

Authors:  Stephania T Miller; Jennifer Cunningham-Erves; Sylvie A Akohoue
Journal:  Ethn Dis       Date:  2016-04-21       Impact factor: 1.847

4.  Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy.

Authors:  Seong Hun Jeong; Jung Il Han; Sung Won Cho; Dong Won Lee; Chul Gu Kim; Tae Gon Lee; Jong Woo Kim
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

5.  Evaluating digital diabetic retinopathy screening in people aged 90 years and over.

Authors:  A Tye; H Wharton; A Wright; Y Yang; J Gibson; A Syed; A Mills; P Dodson
Journal:  Eye (Lond)       Date:  2015-07-17       Impact factor: 3.775

6.  Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

Authors:  Takeshi Kita; Yasuaki Hata; Ryoichi Arita; Shuhei Kawahara; Muneki Miura; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Yoshinobu Goto; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

Review 7.  Treatment of diabetic retinopathy: Recent advances and unresolved challenges.

Authors:  Michael W Stewart
Journal:  World J Diabetes       Date:  2016-08-25

8.  CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes.

Authors:  Eleni Beli; James M Dominguez; Ping Hu; Jeffrey S Thinschmidt; Sergio Caballero; Sergio Li Calzi; Defang Luo; Sumathi Shanmugam; Tatiana E Salazar; Yaqian Duan; Michael E Boulton; Susanna Mohr; Steven F Abcouwer; Daniel R Saban; Jeffrey K Harrison; Maria B Grant
Journal:  J Mol Med (Berl)       Date:  2016-06-25       Impact factor: 4.599

9.  HLA class I and II alleles are associated with microvascular complications of type 1 diabetes.

Authors:  E M Lipner; Y Tomer; J A Noble; M C Monti; J T Lonsdale; B Corso; W C L Stewart; D A Greenberg
Journal:  Hum Immunol       Date:  2013-01-29       Impact factor: 2.850

10.  Advances in the treatment of diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar; Hani S Al-Mezaine
Journal:  Saudi J Ophthalmol       Date:  2011-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.